Estrogen receptor pathways to AP-1

[1]  D. McDonnell,et al.  The Estrogen Receptor ␤-isoform (er␤) of the Human Estrogen Receptor Modulates Er␣ Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens* , 2022 .

[2]  B. Katzenellenbogen,et al.  The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. , 1999, Molecular endocrinology.

[3]  D. Metzger,et al.  Purification and Identification of p68 RNA Helicase Acting as a Transcriptional Coactivator Specific for the Activation Function 1 of Human Estrogen Receptor α , 1999, Molecular and Cellular Biology.

[4]  S. Safe,et al.  Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. , 1999, Molecular endocrinology.

[5]  M. Parker,et al.  Molecular Determinants of the Estrogen Receptor-Coactivator Interface , 1999, Molecular and Cellular Biology.

[6]  V. Giguère,et al.  Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.

[7]  D. McDonnell,et al.  The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. , 1999, Endocrinology.

[8]  D. Metzger,et al.  Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. , 1999, Molecular and cellular biology.

[9]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[10]  B. Katzenellenbogen,et al.  Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.

[11]  J. McClary,et al.  The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant. , 1998, Molecular endocrinology.

[12]  B. Katzenellenbogen,et al.  Estrogen receptor activation function 1 works by binding p160 coactivator proteins. , 1998, Molecular endocrinology.

[13]  T. Archer,et al.  Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. , 1998, Molecular endocrinology.

[14]  A. Philips,et al.  FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. , 1998, Molecular endocrinology.

[15]  R J Fletterick,et al.  Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. , 1998, Science.

[16]  K.,et al.  Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Webb,et al.  The ER/AP1 Pathway: A Window on the Cell-Specific Estrogen-like Effects of Antiestrogens , 1998 .

[18]  H. Gronemeyer,et al.  Molecular Basis of Sex Hormone Receptor Function , 1998, Ernst Schering Research Foundation Workshop.

[19]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[20]  E. Zandi,et al.  Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity , 1997, Molecular and cellular biology.

[21]  P. Webb,et al.  Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. , 1997, Endocrinology.

[22]  K. Horwitz,et al.  The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. , 1997, Molecular endocrinology.

[23]  Woong Sun,et al.  Estrogen‐induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: Differential induction mechanism of cyclin D1 and D3 , 1997, Molecular reproduction and development.

[24]  B. Katzenellenbogen,et al.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  N. Copeland,et al.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.

[26]  R. Goodman,et al.  The multifunctional role of the co-activator CBP in transcriptional regulation. , 1997, Recent progress in hormone research.

[27]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[28]  A. Glasebrook,et al.  Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. , 1997, Science.

[29]  A. Glasebrook,et al.  Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene , 1996, Science.

[30]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[31]  M. Elgort,et al.  Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence. , 1996, Molecular endocrinology.

[32]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[33]  Mary E. McGrath,et al.  A structural role for hormone in the thyroid hormone receptor , 1995, Nature.

[34]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[35]  P. Webb,et al.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.

[36]  H. Rochefort.  Oestrogen- and anti-oestrogen-regulated genes in human breast cancer. , 1995, Ciba Foundation symposium.

[37]  D. Sukovich,et al.  A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element , 1994, Molecular and cellular biology.

[38]  Y. Yamasaki,et al.  Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. , 1994, The Journal of biological chemistry.

[39]  A. Philips,et al.  Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. , 1993, The Journal of biological chemistry.

[40]  R. Shiu,et al.  Mechanism of estrogen activation of c-myc oncogene expression. , 1992, Oncogene.

[41]  M. Pfahl,et al.  Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. , 1991, Molecular endocrinology.

[42]  P. Chambon,et al.  Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex , 1990, Cell.

[43]  P. Chambon,et al.  Cell‐specific activity of a GGTCA half‐palindromic oestrogen‐responsive element in the chicken ovalbumin gene promoter. , 1988, The EMBO journal.

[44]  A. Murdoch.  Cloning , 2007, Ethics & Medics.

[45]  Robert Altenloh.  From a Novel , 1953 .